Compare · RUN vs TMO
RUN vs TMO
Side-by-side comparison of Sunrun Inc. (RUN) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- RUN operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 70.0x RUN ($2.83B).
- Over the past year, RUN is up 13.1% and TMO is up 31.4% - TMO leads by 18.2 points.
- RUN has been more active in the news (13 items in the past 4 weeks vs 7 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Sunrun Inc.
- Thermo Fisher Scientific Inc
- Price
- $11.84-2.67%
- $532.16-2.05%
- Market cap
- $2.83B
- $197.88B
- 1M return
- -6.44%
- +12.59%
- 1Y return
- +13.15%
- +31.37%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 13
- 7
- Recent ratings
- 25
- 25
Sunrun Inc.
Sunrun Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. It also sells solar energy systems and products, such as panels and racking; and solar leads generated to customers. In addition, the company offers battery storage along with solar energy systems. Its primary customers are residential homeowners. The company markets and sells its products through direct-to-consumer approach across online, retail, mass media, digital media, canvassing, field marketing, and referral channels, as well as its partner network. Sunrun Inc. was founded in 2007 and is headquartered in San Francisco, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest RUN
- Sunrun Earns Best Company’s Preferred Partner Award for Customer Service Excellence for the Second Consecutive Year
- Sunrun Announces Date for Second Quarter 2026 Earnings Report
- Sunrun’s California Distributed Power Plant Expands Dispatch Capacity to 425 Megawatts to Provide Statewide Grid Relief
- Chief Accounting Officer Barak Maria sold $39,893 worth of shares (3,278 units at $12.17) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 90,033 units (SEC Form 4)
- Sunrun Launches Distributed AI Data Center Pilot Backed By Existing Home Energy Generation
- Chief Legal & People Officer Steele Jeanna sold $130,517 worth of shares (9,897 units at $13.19), decreasing direct ownership by 2% to 461,715 units (SEC Form 4)
- Chief Executive Officer Powell Mary sold $316,285 worth of shares (23,985 units at $13.19), decreasing direct ownership by 2% to 1,111,535 units (SEC Form 4)
- Pres. & Chief Revenue Officer Dickson Paul S. sold $205,851 worth of shares (15,613 units at $13.18), decreasing direct ownership by 2% to 839,539 units (SEC Form 4)
- Chief Accounting Officer Barak Maria sold $23,013 worth of shares (1,747 units at $13.17), decreasing direct ownership by 2% to 93,311 units (SEC Form 4)
- Chief Financial Officer Abajian Danny sold $217,511 worth of shares (16,495 units at $13.19), gifted 17,052 shares and received a gift of 17,052 shares, decreasing direct ownership by 8% to 403,266 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target